Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DARDAR Health Project (Disseminated Tuberculosis and HIV Infection)

Trial Profile

DARDAR Health Project (Disseminated Tuberculosis and HIV Infection)

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 22 Feb 2016

At a glance

  • Drugs IMM-201 (Primary)
  • Indications Tuberculosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms DARDAR
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 16 Feb 2010 Pharmacodynamic substudy results presented at 17th Conference on Retroviruses and Opportunistic Infections.
    • 29 Jan 2010 Primary endpoint 'Occurrence of infection' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top